A Prospective, Randomized, Placebo-Controlled Trial of Prednisone and Allopurinol in the Prevention of ERCP-Induced Pancreatitis

Background and Study Aims: Patients and Methods: Results: Conclusions:

[1]  E. G. Hahn,et al.  Analysis of the Risk Factors Associated with Endoscopic Sphincterotomy Techniques: Preliminary Results of a Prospective Study, with Emphasis on the Reduced Risk of Acute Pancreatitis with Low-Dose Anticoagulation Treatment , 2000, Endoscopy.

[2]  G. D. Palma,et al.  Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study , 1999, American Journal of Gastroenterology.

[3]  J. Barkin,et al.  Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. , 1998, Gastrointestinal endoscopy.

[4]  J. Ponsky,et al.  Pretreatment With Methylprednisolone to Prevent Ercp-Induced Pancreatitis: A Randomized, Multicenter, Placebo-Controlled Clinical Trial , 1998, American Journal of Gastroenterology.

[5]  T. Frick.  Drug-associated pancreatitis: facts and fiction. , 1997, Pancreas.

[6]  J. Barkin,et al.  Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. , 1997, Gastrointestinal endoscopy.

[7]  T. Zágoni,et al.  Complications of endoscopic biliary sphincterotomy. , 1997, The New England journal of medicine.

[8]  W. Silverman,et al.  Does prophylactic oral steroid administration reduce the frequency and severity of post-ERCP pancreatitis?: Randomized prospective multicenter study , 1996 .

[9]  M. Catalano,et al.  Use of corticosteroids in the prevention of post-ERCP pancreatitis. , 1995, Gastrointestinal endoscopy.

[10]  M. Cicardi,et al.  Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy. , 1995, Gastrointestinal endoscopy.

[11]  A. Rossi,et al.  The Use of a Long-Acting Somatostatin Analogue (Octreotide) for Prophylaxis of Acute Pancreatitis after Endoscopic Sphincterotomy , 1994, Endoscopy.

[12]  W. Silverman,et al.  Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent. , 1994, Gastrointestinal endoscopy.

[13]  Y. K. Chen,et al.  Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. , 1994, The American journal of gastroenterology.

[14]  S. Lamberts,et al.  A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. , 1993, The American journal of gastroenterology.

[15]  K. Binmoeller,et al.  Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? , 1992, Gut.

[16]  R. Hawes,et al.  Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. , 1991, Gastroenterology.

[17]  C Liguory,et al.  Endoscopic sphincterotomy complications and their management: an attempt at consensus. , 1991, Gastrointestinal endoscopy.

[18]  S. Sherman,et al.  ERCP‐ and Endoscopic Sphincterotomy‐Induced Pancreatitis , 1991, Pancreas.

[19]  C. Delaney,et al.  Free radical inhibition and serial chemiluminescence in evolving experimental pancreatitis , 1990, The British journal of surgery.

[20]  H. Gröne,et al.  *Xanthine Oxidase Inhibitor in Acute Experimental Pancreatitis in Rats and Mice , 1989, Pancreas.

[21]  I. Renner,et al.  Allopurinol attenuates caerulein induced acute pancreatitis in the rat. , 1988, Gut.

[22]  H. Rinderknecht.  Fatal pancreatitis, a consequence of excessive leukocyte stimulation? , 1988, International journal of pancreatology : official journal of the International Association of Pancreatology.

[23]  G. Tytgat,et al.  Precut papillotomy via fine-needle knife papillotome: a safe and effective technique. , 1986, Gastrointestinal endoscopy.

[24]  J. Cameron,et al.  The pathogenesis of acute pancreatitis. The source and role of oxygen-derived free radicals in three different experimental models. , 1985, Annals of surgery.

[25]  J. Lang,et al.  Glucocorticoid-induced elevations of C1-esterase inhibitor: a mechanism for protection against lethal dose range contrast challenge in rabbits. , 1980, Investigative radiology.

[26]  J. Grendell,et al.  Intracellular Events in the Pathogenesis of Acute Pancreatitis , 1991, Pancreas.

[27]  Z. Tulassay,et al.  The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography. , 1991, Gastrointestinal endoscopy.

[28]  J. Cameron,et al.  Temporal efficacy of allopurinol during the induction of pancreatitis in the ex vivo perfused canine pancreas. , 1987, Surgery.